|
MOBKL1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.21130000030334E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19759999694935E-08 |
| Normal-vs-Stage2 |
1.795570E-02 |
| Normal-vs-Stage3 |
6.373500E-02 |
| Normal-vs-Stage4 |
7.515500E-02 |
| Stage1-vs-Stage2 |
1.942830E-01 |
| Stage1-vs-Stage3 |
1.461960E-02 |
| Stage1-vs-Stage4 |
4.863000E-01 |
| Stage2-vs-Stage3 |
4.875000E-01 |
| Stage2-vs-Stage4 |
8.281800E-01 |
| Stage3-vs-Stage4 |
4.419400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.39029999524487E-08 |
| Normal-vs-AfricanAmerican |
2.19309999999195E-05 |
| Normal-vs-Asian |
3.026400E-01 |
| Caucasian-vs-AfricanAmerican |
8.912000E-01 |
| Caucasian-vs-Asian |
5.895200E-01 |
| AfricanAmerican-vs-Asian |
6.108400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.97909996671564E-09 |
| Normal-vs-Female |
3.152300E-02 |
| Male-vs-Female |
5.613100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.51560000000362E-05 |
| Normal-vs-Extreme_Weight |
1.67660330063768E-11 |
| Normal-vs-Obese |
3.434000E-04 |
| Normal-vs-Extreme_Obese |
3.279900E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.033200E-01 |
| Normal_Weight-vs-Obese |
3.115800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.203800E-01 |
| Extreme_Weight-vs-Obese |
5.897400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.899200E-01 |
| Obese-vs-Extreme_Obese |
6.184400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.915700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.17280000003317E-06 |
| Normal-vs-Age(61-80Yrs) |
2.34289999623272E-08 |
| Normal-vs-Age(81-100Yrs) |
1.008650E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.286600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.873000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.557400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.993790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.562200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.663000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64820046499869E-10 |
| Normal-VS-Type2 PRCC |
2.663300E-03 |
| Normal-VS-KIRP CIMP |
9.415200E-01 |
| Normal-VS-Unclassified PRCC |
8.221800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.561000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.373780E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.404700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.247190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.856000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.946600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.17950000006518E-07 |
| Normal-vs-N1 |
1.916150E-01 |
| Normal-vs-N2 |
2.837800E-01 |
| N0-vs-N1 |
1.542130E-02 |
| N0-vs-N2 |
9.002600E-01 |
| N1-vs-N2 |
3.593800E-01 |
|
|
